BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1512 related articles for article (PubMed ID: 16643491)

  • 21. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.
    Strauss AL; Coe FL; Parks JH
    Arch Intern Med; 1982 Mar; 142(3):504-7. PubMed ID: 7065787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic factors associated with urinary calculi in children.
    Naseri M; Varasteh AR; Alamdaran SA
    Iran J Kidney Dis; 2010 Jan; 4(1):32-8. PubMed ID: 20081302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing composition of staghorn calculi.
    Viprakasit DP; Sawyer MD; Herrell SD; Miller NL
    J Urol; 2011 Dec; 186(6):2285-90. PubMed ID: 22014820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
    Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
    Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal].
    Serra A; Domingos F; Salgueiro C; Prata MM
    Acta Med Port; 2004; 17(1):27-34. PubMed ID: 15636725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The etiology of urolithiasis in HIV infected patients.
    Nadler RB; Rubenstein JN; Eggener SE; Loor MM; Smith ND
    J Urol; 2003 Feb; 169(2):475-7. PubMed ID: 12544290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of calyceal diverticular stones with extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy: long-term outcome.
    Turna B; Raza A; Moussa S; Smith G; Tolley DA
    BJU Int; 2007 Jul; 100(1):151-6. PubMed ID: 17552962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathogenesis of calyceal diverticular calculi.
    Matlaga BR; Miller NL; Terry C; Kim SC; Kuo RL; Coe FL; Evan AP; Lingeman JE
    Urol Res; 2007 Feb; 35(1):35-40. PubMed ID: 17273836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.
    Eisner BH; Sheth S; Dretler SP; Herrick B; Pais VM
    Urology; 2012 Oct; 80(4):776-9. PubMed ID: 22921696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of diuretic therapy on spontaneous expulsion of urinary calculi, urinary pH, and crystalluria in lithiasic patients].
    Kaid-Omar Z; Belouatek A; Driouch A; Taleb-Bendiab H; Lacour B; Addou A; Daudon M
    Prog Urol; 2001 Jun; 11(3):450-7. PubMed ID: 11512457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.